HYDROLYSIS OF BIG ENDOTHELIN-1 BY A SERINE-PROTEASE IN THE MEMBRANE-FRACTION OF HUMAN LUNG

Citation
Gc. Hanson et al., HYDROLYSIS OF BIG ENDOTHELIN-1 BY A SERINE-PROTEASE IN THE MEMBRANE-FRACTION OF HUMAN LUNG, Regulatory peptides, 68(1), 1997, pp. 63-69
Citations number
27
Categorie Soggetti
Endocrynology & Metabolism",Physiology
Journal title
ISSN journal
01670115
Volume
68
Issue
1
Year of publication
1997
Pages
63 - 69
Database
ISI
SICI code
0167-0115(1997)68:1<63:HOBEBA>2.0.ZU;2-V
Abstract
The hydrolysis of human big endothelin(1-38) (bigET-1) was investigate d in the membrane fractions from three human lung specimens. The hydro lysis products were identified by HPLC or by amino acid analysis, pept ide sequencing and mass spectrometry, and the contractile effects of s ynthetic bigET-1, synthetic ET-1 and the major metabolite were tested on isolated rabbit pulmonary arteries. The dominating hydrolysis produ ct was identified as bigET(1-31), formed by a chymostatin-sensitive en zyme. Soybean trypsin inhibitor also suppressed bigET(1-31) formation, while two other serine protease inhibitors, 3,4-dichloroisocoumarin a nd aprotinin, had no (or a limited) inhibitory effect. Through a partl y phosphoramidon-sensitive enzymatic activity, endothelin-1 (ET-1) was formed independently of bigET(1-31). On isolated pulmonary arteries, bigET(1-31) had a contractile effect similar to that of synthetic bigE T-1, with pEC(50%) values of 7.3+/-0.1 (n = 6) and 7.1+/-0.1 (n = 8), respectively. The pEC(50%) value of ET-1 was 9.2+/-0.3 (n = 6). These results indicate that human pulmonary membranes, besides hydrolysing b igET-1 to ET-1, also express serine protease activity that is responsi ble for the formation of the biologically active product, bigET(1-31). (C) 1997 Elsevier Science B.V.